T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Microvision
MVIS
$89.7M
| $478K | ﹤0.01% |
8,292
+366
| +5% | +$19.6K |
|
|
FSR
2227
DELISTED
Fisker Inc.
FSR
| $478K | ﹤0.01% |
55,756
+15,426
| +38% | +$160K |
|
2228
Sprinklr
CXM
$1.58B
| $477K | ﹤0.01% |
+47,147
| New | +$572K |
|
2229
Schrodinger
SDGR
$1.38B
| $477K | ﹤0.01% |
18,048
-258,042
| -93% | -$6.93M |
|
|
MNTV
2230
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $477K | ﹤0.01% |
54,214
+3,190
| +6% | +$42.7K |
|
2231
Funko
FNKO
$331M
| $476K | ﹤0.01% |
21,338
+604
| +3% | +$11.7K |
|
2232
Coursera
COUR
$1.48B
| $474K | ﹤0.01% |
33,461
+4,225
| +14% | +$75.3K |
|
|
CNR
2233
Core Natural Resources Inc
CNR
$4.71B
| $474K | ﹤0.01% |
9,590
-1,246
| -11% | -$60.7K |
|
2234
ZIM Integrated Shipping Services
ZIM
$3.23B
| $472K | ﹤0.01% |
+10,000
| New | +$587K |
|
2235
Progress Software
PRGS
$1.79B
| $470K | ﹤0.01% |
10,372
+310
| +3% | +$14.8K |
|
|
MRC
2236
DELISTED
MRC Global
MRC
| $466K | ﹤0.01% |
46,820
-4,392
| -9% | -$48.7K |
|
2237
Vishay Precision Group
VPG
$908M
| $466K | ﹤0.01% |
16,000
+36
| +0.2% | +$1.1K |
|
|
ACRE
2238
Ares Commercial Real Estate
ACRE
$261M
| $465K | ﹤0.01% |
38,043
+241
| +0.6% | +$3.5K |
|
2239
SkinHealth Systems
SKIN
$84.2M
| $464K | ﹤0.01% |
36,118
+12,702
| +54% | +$170K |
|
|
SCS
2240
DELISTED
Steelcase
SCS
| $463K | ﹤0.01% |
43,147
+685
| +2% | +$7.92K |
|
2241
Zumiez
ZUMZ
$318M
| $462K | ﹤0.01% |
+17,764
| New | +$598K |
|
2242
ZTO Express
ZTO
$17.6B
| $461K | ﹤0.01% |
16,800
-291,400
| -95% | -$7.47M |
|
2243
Krystal Biotech
KRYS
$9.72B
| $458K | ﹤0.01% |
6,976
-2,497
| -26% | -$155K |
|
2244
Movado Group
MOV
$815M
| $458K | ﹤0.01% |
14,819
-2,643
| -15% | -$92.7K |
|
2245
Vicor
VICR
$10.4B
| $457K | ﹤0.01% |
8,352
+212
| +3% | +$13.1K |
|
2246
National Healthcare
NHC
$3.47B
| $454K | ﹤0.01% |
6,496
+668
| +11% | +$46.8K |
|
2247
Collegium Pharmaceutical
COLL
$913M
| $453K | ﹤0.01% |
25,580
+1,425
| +6% | +$24K |
|
2248
G-III Apparel Group
GIII
$1.41B
| $451K | ﹤0.01% |
22,282
+321
| +1% | +$8.11K |
|
|
HOUS
2249
DELISTED
Anywhere Real Estate
HOUS
| $451K | ﹤0.01% |
45,894
-10,335
| -18% | -$122K |
|
2250
MannKind Corp
MNKD
$1.24B
| $451K | ﹤0.01% |
118,267
+6,551
| +6% | +$24.1K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.